
Immuron Limited IMRN
€ 0.65
-6.67%
Geschäftsbericht 2022
hinzugefügt 09.09.2022
Immuron Limited DIO 2011-2026 | IMRN
DIO Jährlich Immuron Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.32 K | 2.33 K | 2.53 K | - | - | - | - | - | - |
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.53 K | 1.32 K | 2.06 K |
DIO anderer Aktien in der Pharmaeinzelhändler
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Alnylam Pharmaceuticals
ALNY
|
43.5 | $ 326.56 | -2.05 % | $ 42.8 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
166 | $ 21.48 | -0.92 % | $ 1 B | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Akebia Therapeutics
AKBA
|
147 | $ 1.41 | -9.12 % | $ 363 M | ||
|
Aquestive Therapeutics
AQST
|
120 | $ 4.16 | -1.89 % | $ 445 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 24.22 | -1.46 % | $ 3.08 B | ||
|
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.48 | -0.67 % | $ 394 M | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Caladrius Biosciences
CLBS
|
35.8 | - | -16.75 % | $ 25.8 M | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B |